Novavax | NVAX - 貿易債権者





貿易債権者 変化する 日付
Adma Biologics USD 22.52M 1.5M 2025-12
Agenus USD 82.99M 2.3M 2025-12
AstraZeneca USD 22.51B 2.78B 2026-03
BioCryst Pharmaceuticals USD 15.83M 10.26M 2025-12
Cassava Sciences USD 41.65M 4.44M 2025-12
Geron USD 11.26M 146K 2025-12
GlaxoSmithKline GBP 14.34B 1.05B 2026-03
MannKind USD 9.03M 1.76M 2025-12
Merck USD 3.86B 541M 2026-03
Minerva Neurosciences USD 640K 305K 2025-12
Moderna USD 161M 156M 2026-03
Novartis USD 4.46B 99M 2025-12
Novavax USD 24.58M 9.35M 2025-12
Pfizer USD 4.51B 734M 2026-03
Sanofi EUR 22.71B 219M 2026-03
Sarepta Therapeutics USD 280.84M 186.83M 2025-12
TG Therapeutics USD 61.64M 72.38M 2025-09